Latest Blogs

Apr 27, 2017
When you see enough remarkable recoveries, it becomes tempting to believe it is not only the drugs—that it is you. Where there is the Lazarus effect, perhaps there is the resurgence of the God complex as well.
Apr 20, 2017
Get the most out of your experience at the ASCO Annual Meeting by making preparations and familiarizing yourself with the program and materials before you arrive in Chicago.
Apr 18, 2017
I want to thank and pay tribute to the oncology nurses who are a true blessing and essential to providing exceptional care for my patients.
Apr 14, 2017
When faced with a suffering patient and family, it can be all too easy to blame yourself for their pain. Dr. Nasser Hanna encourages you to remember that the cancer is at fault, not you.
Subscribe to this column

Daniel F. Hayes, MD, FACP, FASCO

Daniel F. Hayes, MD, FACP, FASCO, is the 2016-2017 ASCO President. Dr. Hayes, a breast cancer specialist, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center.

An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Dec 22, 2016
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.
Nov 28, 2016
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs.  Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.  
Oct 25, 2016
“When are we going to cure cancer?” If I had a dime for every time I’ve been asked that...The trite answer is that we already cure many cancers, just not enough of them! But the real question should be, “Why don’t we cure all cancers?”
Oct 18, 2016
Vice President Joe Biden and the government-wide Cancer Moonshot Task Force have presented today a sweeping vision that, if realized, could change the face of cancer prevention, screening, treatment, and survivorship as we know it.
Aug 24, 2016
Support for federal research funding for cancer is not about politics. It's about people. There is no one in our society—liberal, conservative, libertarian, or just don’t care—who isn’t touched in some way by cancer.
Jul 11, 2016
Believe it or not, the Medicare Access and CHIP Reauthorization Act of 2015 was passed more than 1 year ago, and program changes begin in less than six months, on Janurary 1, 2017.

Pages